Trademark: 87366594
Word
XERETIQ
Status
Dead
Status Code
606
Status Date
Monday, October 26, 2020
Serial Number
87366594
Mark Type
4000
Filing Date
Friday, March 10, 2017
Published for Opposition
Tuesday, July 25, 2017
Abandoned Date
Monday, October 26, 2020

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting sensory organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting the central nervous system; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting urogenital organs; Pharmaceuticals and medicines for the prevention and treatment of conditions affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular disease and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, central nervous system (CNS) disorders, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin; Pharmaceutical preparations used in connection with and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile antibiotic and anti-inflammatory ointments; ocular wetting solutions, namely, eye drops, artificial tears and gels for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body
The word "XERETIQ" has no meaning in a foreign language.

Trademark Events
Oct 26, 2020
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 26, 2020
Abandonment - No Use Statement Filed
Mar 21, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 20, 2020
Extension 5 Granted
Mar 13, 2020
Extension 5 Filed
Mar 20, 2020
Case Assigned To Intent To Use Paralegal
Mar 13, 2020
Teas Extension Received
Sep 18, 2019
Notice Of Approval Of Extension Request E-Mailed
Sep 16, 2019
Extension 4 Granted
Sep 16, 2019
Extension 4 Filed
Sep 16, 2019
Teas Extension Received
Mar 5, 2019
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2019
Extension 3 Granted
Mar 1, 2019
Extension 3 Filed
Mar 1, 2019
Teas Extension Received
Sep 11, 2018
Notice Of Approval Of Extension Request E-Mailed
Sep 7, 2018
Extension 2 Granted
Sep 7, 2018
Extension 2 Filed
Sep 7, 2018
Teas Extension Received
Feb 1, 2018
Notice Of Approval Of Extension Request E-Mailed
Jan 30, 2018
Extension 1 Granted
Jan 30, 2018
Extension 1 Filed
Jan 30, 2018
Teas Extension Received
Sep 19, 2017
Noa E-Mailed - Sou Required From Applicant
Jul 25, 2017
Official Gazette Publication Confirmation E-Mailed
Jul 25, 2017
Published For Opposition
Jul 5, 2017
Notification Of Notice Of Publication E-Mailed
Jun 21, 2017
Law Office Publication Review Completed
Jun 20, 2017
Assigned To Lie
May 12, 2017
Approved For Pub - Principal Register
May 12, 2017
Examiner's Amendment Entered
May 12, 2017
Notification Of Examiners Amendment E-Mailed
May 12, 2017
Examiners Amendment E-Mailed
May 12, 2017
Examiners Amendment -Written
May 9, 2017
Assigned To Examiner
Mar 16, 2017
New Application Office Supplied Data Entered In Tram
Mar 14, 2017
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24